– UK, London – KRM22 Plc (LON: KRM), the technology and software investment company that focuses on risk management for capital markets, today announced the appointment of Steve Sparke as a Non-Executive Director of the Company.
Mr Sparke will replace Matt Reed, Independent Non-Executive Director, who notified the Board of his intention to step down from the Board with immediate effect after being with the Company since its IPO in early 2018. Mr Reed is stepping down to focus on other business commitments.
With the resignation of Matt and the appointment of Steve, the Board remains comprised of four Independent Non-Executive Directors and the two Executive Directors. In addition to his role as a Non-Executive Director, Steve will replace Matt as Audit Committee Chairman.
“We are delighted to welcome Steve to the KRM22 Board. Steve brings deep industry knowledge and expertise of capital markets and will be a real asset to the Company,” said Keith Todd, Executive Chairman.
“All the team would like to thank Matt for his valuable contributions since KRM22’s IPO and we wish him well for the future,” he added.
About Steve Sparke
Steve has over 30 years’ experience in the Exchange Traded Derivatives and Commodity industry with extensive board-level experience for global ETD and Commodities organisations. He has a deep understanding of the application of IT for strategic advantage and extensive expertise in optimising operational functions included technology, legal, risk and compliance.
Steve was recently COO of Marex Spectron where he was responsible for the firm’s operating environment including operations, risk, compliance and HR. During his time at Marex, he expanded the global footprint of the organisation with new regulated entities and offices opened in New York and Hong Kong, boosted the firm’s presence in Singapore and transformed the firm’s operating model, facilitating growth to become Europe’s largest independent commodity broker. He directed the integration of multiple businesses, including the high profile Spectron acquisition. Prior to joining Marex Spectron, he was Managing Director and Global Head of Exchange Traded Derivatives at UBS from 1994 to 2006 where he launched and led the bank’s ETD Clearing and Execution business. Steve headed the Short Term Interest Rates business at SBC London Branch from 1987 to 1994.
Steve is a currently non-executive Chairman of FIA European Advisory Board and has held various board positions at FIA Washington and NYSE Euronext LIFFE. Steve was also a non-executive director of AIM-listed PATS Systems, a provider of high-performance electronic trading and exchange systems for 5 years between 2006 and 2011, during which time he helped re-establish the firms’ growth trajectory after an extended period of declining market share.
About KRM22 plc
KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.
Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms’ regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.
Capital markets companies’ partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.
KRM22 PLC is listed on AIM and the Group is headquartered in London, with offices in several of the world’s major financial centres.
For more information: https://krm22.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.